QA: Dynavax Technologies CORP in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001029142_2025_Dynavax_Technologies_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001029142, Dynavax Technologies CORP

  xvar xval
0 AssetsCurrent 848,941,000
1 IntangibleAssetsNetIncludingGoodwill 1,946,000
2 PropertyPlantAndEquipmentNet 39,001,000
3 remainder_Assets 96,368,000
4 LiabilitiesCurrent 78,634,000
5 LiabilitiesNoncurrent 26,632,000
6 remainder_Liabilities 284,191,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 171,311,067
9 ResearchAndDevelopmentExpense 61,994,098
10 remainder_Expenses 60,128,963
11 remainder_Revenues 282,025,442
12 remainder_NetIncome 38,162,426
13 remainder_ComprehensiveNetIncome -2,693,314
  yvar yval
0 Assets 986,256,000
1 Liabilities 389,457,000
2 Expenses 293,434,128
3 Revenues 282,025,442
4 StockholdersEquity 596,799,000
5 NetIncome 26,753,740
6 ComprehensiveNetIncome 25,407,083
7 BaseVar 996,014,155
8 EconomicCapitalRatiobeforeLimitedLiability 1.93
9 EconomicCapitalRatio 2.98

Edgar->Model Mapping

Feature Distribution

Change over Time